ProQR Therapeutics (PRQR) Change in Accured Expenses (2019 - 2026)
Powered by 
Analysis
ProQR Therapeutics (PRQR) Change in Accured Expenses (2019 - 2026) Analysis & Trends
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 222.50 Mn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 492.70 Mn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 11.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | 55.78 Mn |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 212.44 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 61.62 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 68.82 Mn |
| 10 | ProQR Therapeutics | 218.57 Mn | 82.18 Mn | - | -721,826.71 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -721,826.71 |
| Mar 31, 2026 | -355,906.68 |
| Dec 31, 2025 | -699,590.15 |
| Sep 30, 2025 | -519,060.46 |
| Jun 30, 2025 | -331,664.19 |
| Mar 31, 2025 | -596,418.48 |
| Dec 31, 2024 | -270,354.64 |
| Sep 30, 2024 | -498,591.65 |
| Jun 30, 2024 | -316,604.95 |
| Mar 31, 2024 | -631,176.19 |
| Dec 31, 2023 | -304,490.99 |
| Sep 30, 2023 | -470,271.09 |
| Jun 30, 2023 | -704,534.08 |
| Mar 31, 2023 | -277,995.53 |
| Dec 31, 2022 | -367,289.05 |
| Sep 30, 2022 | -384,152.52 |
| Jun 30, 2022 | -380,939.24 |
| Mar 31, 2022 | -646,466.53 |
| Dec 31, 2021 | -255,105.52 |
| Sep 30, 2021 | -409,212.70 |